<DOC>
<DOCNO>EP-0625504</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Stable and crystaline form of Bezafibrate
</INVENTION-TITLE>
<CLASSIFICATIONS>C07C23373	C07C23100	C07C23300	C07C23122	C07C23124	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07C	C07C	C07C	C07C	C07C	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07C233	C07C231	C07C233	C07C231	C07C231	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
There is described a crystal form of 2-[4-[2-(4-chlorobenzoylamino)ethyl]phenoxy-2-methylpropionic acid (INN: bezafibrate) designated as the  beta -form, which is characterised by its FT-infrared spectrum in potassium bromide with absorption bands at the following wavenumbers. 
<
IMAGE
>
 On account of its crystalline properties, the form offers advantages in pharmaceutical processing to give solid pharmaceutical forms.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HEUMANN PHARMA GMBH 
&
 CO
</APPLICANT-NAME>
<APPLICANT-NAME>
HEUMANN PHARMA GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
AHRENS KURT-HENNING DR APOTHEK
</INVENTOR-NAME>
<INVENTOR-NAME>
MAIER PETER CHEMIKANT
</INVENTOR-NAME>
<INVENTOR-NAME>
MOERSDORF PETER DR DIPL CHEM
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHMITT JOSEF CHEMIEINGENIEUR
</INVENTOR-NAME>
<INVENTOR-NAME>
AHRENS, KURT-HENNING DR. APOTHEKER
</INVENTOR-NAME>
<INVENTOR-NAME>
MAIER, PETER CHEMIKANT
</INVENTOR-NAME>
<INVENTOR-NAME>
MOERSDORF, PETER DR. DIPL. CHEM.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHMITT, JOSEF CHEMIEINGENIEUR
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
New, crystalline Î²-form of 2-[4-[2-(4-chlorobenzoylamino)ethyl]phenoxy]
-2-methylpropionic 
acid, 

characterised by its FT infrared spectrum in potassium 
bromide with absorption bands at the following wave 

numbers: 

3389 cm
-1
847 cm
-1
1740 cm
-1
821 cm
-1
1328 cm
-1
618 cm
-1
606 cm
-1
</CLAIMS>
</TEXT>
</DOC>
